Skip to content

effect of almond fruit in IBS patients

The effect of almond fruit (Prunus amygdalus L.) on sevirity of symptoms in irritable bowel syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017070234861N1
Enrollment
50
Registered
2017-10-09
Start date
2016-12-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irritable bowel syndrome. Irritable bowel syndrome with diarrhoea

Interventions

Intervention 1: The intervention group containsf 25 patients treated with sachets containing 40 grams of almond granules daily for 20 days. Intervention 2: Placebo group recieved equal amount of whea
Treatment - Drugs
The intervention group containsf 25 patients treated with sachets containing 40 grams of almond granules daily for 20 days
Placebo group recieved equal amount of wheat flour granul daily for 20 days

Sponsors

Kerman University of Medical Sciences, Vice Chanellor of Research
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Criteria for entering the study are the presence of Rome III cirrhosis, which include: pain; recurrent abdominal discomfort for at least three days a month in the last three months, with the elimination of two of the following: defecation with bowel movements; The onset of symptoms with a change in the frequency of bowel movements; the onset of symptoms along with a change in the stool shape; Exclusion criteria withdrawal criteria for patients who did not take the medicine on a regular basis; patients who did not complete the assessment form completely

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain location. Timepoint: 20 day. Method of measurement: Data validation form.;Pain consequency. Timepoint: days 0 and 20. Method of measurement: data evaluation form.;Pain consequency. Timepoint: days 0 and 20. Method of measurement: data evaluation form.;Pain intensity. Timepoint: days 0 and 20. Method of measurement: data evaluation form.

Secondary

MeasureTime frame
Buttal in daily functio. Timepoint: 20 day. Method of measurement: Data validation form.;.pain intensity. Timepoint: days 0 and 20. Method of measurement: data evaluation form.;Analgesic drug taking. Timepoint: days 0 and 20. Method of measurement: data evaluation form.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahnaz Azimipour

Afzalipour Hospital

mahnazazimi20@yahoo.com+98 34 3132 8000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026